1. OP0250 EFFICACY AND SAFETY OF ROMILKIMAB IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 24-WEEK, PROOF OF CONCEPT STUDY. (2nd June 2020) Authors: Allanore, Y.; Wung, P.; Soubrane, C.; Esperet, C.; Frederic, M.; Bejuit, R.; Lahmar, A.; Khanna, D.; Denton, C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pseudomyxoma peritonei from ovarian origin. Report on 18 cases from French collaborative network RENAPE. Issue 2 (February 2019) Authors: Gertych, W.; Quenet, F.; Ferron, G.; Goere, D.; Gerard, L.; Frederic, M.; Decullier, E.; Laurent, V.; Glehen, O. Journal: European journal of surgical oncology Issue: Volume 45:Issue 2(2019) Page Start: e65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗